PMDA drug package insert
セプトカイン配合注カートリッジ
PMDA Prescription drug · 株式会社ジーシー昭和薬品 · package insert Mar 17, 2026
Key facts
| Brand names | セプトカイン配合注カートリッジ |
|---|---|
| Nonproprietary names | アルチカイン塩酸塩・アドレナリン酒石酸水素塩 |
| Companies | 製造販売元／株式会社ジーシー昭和薬品, 製造元／NOVOCOL PHARMACEUTICAL OF CANADA INC.ノボコール社（カナダ）, 提携先／セプトドント社（フランス） |
| Product type | Prescription drug |
| Therapeutic category | 歯科用局所麻酔剤 |
| Therapeutic category codes | 87271 |
| YJ codes | 2710821U1026 |
| Approval numbers | 30600AMX00244000 |
| Package insert edition | 第3版 |
| Package insert date | Mar 17, 2026 |
| PMDA document key | 671610_2710821U1026_1 |
| PMDA company code | 671610 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: